(Q44844484)

6 December 2017

0 references

Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients (English)

1 reference

6 December 2017

1 reference

1 reference

Marika Schubert

1

1 reference

6 December 2017

Raman Venkataramanan

2

1 reference

6 December 2017

David W Holt

3

1 reference

6 December 2017

Leslie M Shaw

4

1 reference

6 December 2017

William McGhee

5

1 reference

6 December 2017

Jorge Reyes

6

1 reference

6 December 2017

Steve Webber

7

1 reference

6 December 2017

Rakesh Sindhi

8

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

American Journal of Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

4

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

767-773

1 reference

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Orthotopic liver transplantation using low-dose tacrolimus and sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Pharmacokinetics and metabolism of sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Pharmacokinetics of tacrolimus in paediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Pharmacokinetics of tacrolimus-based combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00411.X

10.1111/J.1600-6143.2004.00411.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference